Mirabegron
NDC 67877-890, Mirabegron, for suspension, extended release, from Ascend Laboratories, LLC.
- Product NDC
- 67877-890
- Status
- Listed
- Labeler
- Ascend Laboratories, LLC
- Dosage form
- FOR SUSPENSION, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219323
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67877-890 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MIRABEGRON8 mg/mL
Pharmacologic classes
Adrenergic beta3-Agonists [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; beta3-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67877-890-88 | 67877089088 | 1 POUCH in 1 CARTON (67877-890-88) / 1 BOTTLE in 1 POUCH / 100 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1c9022af-4841-4f3f-9737-1c5eef58e86bNADAC price for package 67877089088
GET /v1/drugs/nadac/67877089088
Use it
Look up 67877-890 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67877-890 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67877-890. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.